CIK 1126234

LUMOS PHARMA, INC.

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

0.4%

GENENTECH INC · FY to 2018-12-31

Named-customer revenue

$4.8K

1 customer · FY to 2018-12-31

Latest period

Dec 31, 2018

10-K filed 2019-03-05

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies LUMOS PHARMA, INC. discloses as major customers, as a share of LUMOS PHARMA, INC. revenue. 1 active, 0 lapsed.

Company	% of LUMOS PHARMA, INC. revenue	Est. revenue	Period	Trend	Status	Source
GENENTECH INC GENENTECH INC	0.4%	$4.8K	FY 2018-12-31	−0.8pp	Active	10-K 2019-03-05
Genentech, a member of the Roche Group, and Merck Sharpe and Dohme Corp., or Merck, accounted for 0.4% and 9.2%, respectively, of the $12.5 million of revenue for the year ended December 31, 2018, with the remainder obtained from government grants. 10-K filed 2019-03-05 Period FY 2018-01-01 to 2018-12-31 (0.4%)Accession 0001126234-19-000026 Genentech and Merck accounted for 1.2% and 0.2%, respectively, of the $28.7 million of revenue earned for the year ended December 31, 2017, with the remainder obtained from government grants. 10-K filed 2019-03-05 Period FY 2017-01-01 to 2017-12-31 (1.2%)Accession 0001126234-19-000026 Genentech and Merck accounted for 7.6% and 2.3%, respectively, of the $35.8 million of revenue earned for the year ended December 31, 2016, with the remainder obtained from government grants. 10-K filed 2019-03-05 Period FY 2016-01-01 to 2016-12-31 (7.6%)Accession 0001126234-19-000026

Alerts are coming

Get an email when LUMOS PHARMA, INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.